72
Views
2
CrossRef citations to date
0
Altmetric
Letter to the Editor

Interactions between four gene polymorphisms and their association with patients with Parkinson's disease in a Chinese Han population

, , , &
Pages 1154-1160 | Received 11 May 2016, Accepted 16 May 2017, Published online: 01 Jun 2017

References

  • Lv Z, Tang B, Sun Q, et al. Association study between vitamin d receptor gene polymorphisms and patients with Parkinson disease in Chinese Han population. Int J Neurosci 2013;123(1):60–4.
  • Pihlstrøm L, Rengmark A, Bjørnarå KA, et al. Fine mapping and resequencing of the PARK16 locus in Parkinson's disease. J Hum Genet 2015;60(7):357–62.
  • Liu X, Cheng R, Verbitsky M, et al. Genome-wide association study identifies candidate genes for Parkinson's disease in an Ashkenazi Jewish population. BMC Med Genet 2011;12:104.
  • Ayuso P, Martínez C, Pastor P, et al. An association study between heme oxygenase-1 genetic variants and Parkinson's disease. Front Cell Neurosci 2014;8:298.
  • Sonmez E, Ozel MD, Islek EE, et al. Association of rs62063857 variant of the saitohin gene with Parkinson's disease. Cell Mol Neurobiol 2015;35(1):115–21.
  • International Parkinson's Disease Genomics Consortium (IPDGC); Wellcome Trust Case Control Consortium 2 (WTCCC2). A two-stage meta-analysis identifies several new loci for Parkinson's disease. PLoS Genet 2011;7(6):e1002142.
  • Satake W, Nakabayashi Y, Mizuta I, et al. Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nat Genet 2009;41(12):1303–7.
  • Vacic V, Ozelius LJ, Clark LN, et al. Genome-wide mapping of IBD segments in an Ashkenazi PD cohort identifies associated haplotypes. Hum Mol Genet 2014;23(17):4693–702.
  • Lorenzi C, Marcone A, Pirovano A, et al. Serotonin transporter and saitohin genes in risk of Alzheimer's disease and frontotemporal lobar dementia: preliminary findings. Neurol Sci 2010;31(6):741–9.
  • Wang B, Zhou S, Yang Z, et al. Genetic analysis of tumor necrosis factor-alpha (TNF-alpha) G-308A and Saitohin Q7R polymorphisms with Alzheimer's disease. J Neurol Sci 2008;270(1–2):148–51.
  • Zuo L, van Dyck CH, Luo X, et al. Variation at APOE and STH loci and Alzheimer's disease. Behav Brain Funct 2006;2:13.
  • Mateo I, Infante J, Llorca J, et al. Association between glycogen synthase kinase-3 beta genetic polymorphism and late-onset Alzheimer's disease. Dement Geriatr Cogn Disord 2006;21(4):228–32.
  • Lin K, Tang M, Guo Y, et al. The Q7R polymorphism in the saitohin gene is rare in a southern Chinese population. Neurol Sci 2008;29(6):431–4.
  • Johansson A, Zetterberg H, Håkansson A, et al. TAU haplotype and the Saitohin Q7R gene polymorphism do not influence CSF Tau in Alzheimer's disease and are not associated with frontotemporal dementia or Parkinson's disease. Neurodegener Dis 2005;2(1):28–35.
  • Lu SS, Gong FF, Feng F, et al. Association of microtubule associated protein tau/Saitohin (MAPT/STH) MAPT_238bp/STH Q7Rpolymorphisms and Parkinson's disease: a meta-analysis. Biochem Biophys Res Commun 2014;453(3):653–61.
  • National Collaborating Centre for Chronic Conditions (UK). Parkinson's disease: national clinical guideline for diagnosis and management in primary and secondary care. London: Royal College of Physicians; 2006.
  • Lv Z, Guo J, Sun Q, et al. Association between PLA2G6 gene polymorphisms and Parkinson's disease in the Chinese Han population. Parkinsonism Relat Disord 2012;18(5):641–4.
  • Miyake Y, Tanaka K, Fukushima W, et al. PARK16 polymorphisms, interaction with smoking, and sporadic Parkinson's disease in Japan. J Neurol Sci 2016;362:47–52.
  • Xia H, Luo Q, Li XX, et al. Association between PARK16 gene polymorphisms and susceptibility of Parkinson's disease in a Chinese population. Genet Mol Res 2015;14(2):2978–85.
  • Guo JF, Li K, Yu RL, et al. Polygenic determinants of Parkinson's disease in a Chinese population. Neurobiol Aging 2015;36(4):1765.
  • Zhou LL, Zhang X, Bao QQ, et al. Association analysis of PARK16-18 variants and Parkinson's disease in a Chinese population. J Clin Neurosci 2014;21(6):1029–32.
  • Chang K-H, Chen C-M, Chen Y-C, et al. Association between PARK16 and Parkinson's disease in the Han Chinese population: a meta-analysis. Neurobiol Aging 2013;34(10):2442. e5–e9.
  • Yan YP, Mo XY, Tian J, et al. An association between the PARK16 locus and Parkinson's disease in a cohort from eastern China. Parkinsonism Relat Disord 2011;17(10):737–9.
  • Chang XL, Mao XY, Li HH, et al. Association of GWAS loci with PD in China. Am J Med Genet B Neuropsychiatr Genet 2011;156B(3):334–9.
  • Li H, Teo YY, Tan EK. Patterns of linkage disequilibrium at PARK16 may explain variances in genetic association studies. Mov Disord 2015;30(10):1335–42.
  • Infante J, García-Gorostiaga I, Sánchez-Juan P, et al. Synergistic effect of two oxidative stress-related genes (heme oxygenase-1and GSK3β) on the risk of Parkinson's disease. Eur J Neurol 2010;17(5):760–2.
  • Chen J. Hemeoxygenase in neuroprotection: from mechanisms to therapeutic implications. Rev Neurosci 2014;25(2):269–80.
  • Agúndez JA, García-Martín E, Martínez C, et al. Heme oxygenase-1 and 2 common genetic variants and risk for multiple sclerosis. Sci Rep 2016;6:20830.
  • García-Martín E, Jiménez-Jiménez FJ, Alonso-Navarro H, et al. Heme oxygenase-1 and 2 common genetic variants and risk for restless legs syndrome. Medicine (Baltimore) 2015;94(34):e1448.
  • Ayuso P, Agúndez JA, Alonso-Navarro H, et al. Heme oxygenase 1 and 2 common genetic variants and risk for essential tremor. Medicine (Baltimore) 2015;94:e968.
  • Cao L, Zhang Z, Cai B, et al. Association of heme oxygenase-1 gene rs2071746 polymorphism with vascular outcomes in patients with atherosclerotic stroke. J Neurol Sci 2014;344(1–2):154–7.
  • Loboda A, Damulewicz M, Pyza E, et al. Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism. Cell Mol Life Sci 2016;73(17):3221–47.
  • Conrad C, Vianna C, Freeman M, et al. A polymorphic gene nested within an intron of the tau gene: implications for Alzheimer's disease. Proc Natl Acad Sci USA 2002;99(11):7751–6.
  • Holzer M, Craxton M, Jakes R, et al. Tau gene (MAPT) sequence variation among primates. Gene 2004;341:313–22.
  • Tang BL. Rabs, Membrane Dynamics, and Parkinson's Disease. J Cell Physiol 2017;232(7):1626–33.
  • MacLeod DA, Rhinn H, Kuwahara T, et al. RAB7L1 interacts with LRRK2 to modify intraneuronal protein sorting and Parkinson's disease risk. Neuron 2013;77(3):425–39.
  • Kuwahara T, Inoue K, D'Agati VD, et al. LRRK2 and RAB7L1 coordinately regulate axonal morphology and lysosome integrity in diverse cellular contexts. Sci Rep 2016;6:29945.
  • Steger M, Tonelli F, Ito G, et al. Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates asubset of Rab GTPases. Elife 2016;5:e12813.
  • Shimizu F, Katagiri T, Suzuki M, et al. Cloning and chromosome assignment to 1q32 of a human cDNA (RAB7L1) encoding a small GTP-binding protein, a member of the RAS superfamily. Cytogenet Cell Genet 1997;77(3–4):261–3.
  • Goytain A, Quamme GA. Functional characterization of human SLC41A1, a Mg2+ transporter with similarity to prokaryotic MgtE Mg2+ transporters. Physiol Genomics 2005;21(3):337–42.
  • Kikuchi A, Ishikawa T, Mogushi K, et al. Identification of NUCKS1 as a colorectal cancer prognostic marker through integrated expression and copy number analysis. Int J Cancer 2013;132(10):2295–302.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.